Target intelligence / Profile preview

SID1 transmembrane family member 1 (SIDT1)

Target
SIDT1
Molecular classification
Transporter (dsRNA transporter/channel), Enzyme (ceramidase activity)
01

Overview

SID1 transmembrane family member 1 (SIDT1) is a membrane protein composed of 11 transmembrane segments, forming functional homodimers at the plasma membrane. Structurally and functionally related to its C. elegans homolog SID-1, SIDT1 enables uptake of dsRNA and dietary miRNAs, especially under low pH conditions, facilitating systemic RNA interference and posttranscriptional gene silencing. In addition to its RNA transport function, SIDT1 possesses ceramidase enzyme activity, tightly regulated by its interactions with cholesterol via conserved CRAC domains. Cholesterol binding causes conformational changes that modulate lipid hydrolytic activity. SIDT1 is implicated in immune response, tumorigenesis, and chemoresistance (notably involving microRNA-21 in cancer cells). It interacts with RNA and lipid molecules, but no direct pharmacological inhibitors or activators have yet been clinically detailed.

Other names
SIDT1SID1FLJ20174SID1 transmembrane family member 1SID-1
02

Mechanism of action

Facilitation of dsRNA/miRNA/siRNA cellular uptake (energy-independent dsRNA transport); Lipid hydrolytic activity modulated by cholesterol binding (ceramidase activity sensitive to allosteric cholesterol regulation)

03

Biological functions

Double-stranded RNA (dsRNA) uptakeSystemic RNA interference (non–cell-autonomous RNAi)Cholesterol and lipid metabolism (intracellular cholesterol transport, ceramidase activity)Cellular uptake of small interfering RNA (siRNA) and microRNA (miRNA)Posttranscriptional gene silencing
04

Disease associations

Cancer (SIDT1 has been implicated in chemoresistance through transfer of microRNA-21)TumorigenesisInnate immunityGlucose and lipid metabolism disorders
05

Safety considerations

Therapeutic modulation of SIDT1 (e.g., increasing systemic RNAi or altering lipid metabolism) might affect gene regulation and lipid homeostasis; concerns would include possible off-target effects on cellular RNA interference and cholesterol metabolism
06

Biomarkers

microRNA-21 (implicated in chemoresistance and as a functional biomarker for RNA transport activity in some cancers)

Beyond the preview

Go deeper on SID1 transmembrane family member 1 (SIDT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SID1 transmembrane family member 1 (SIDT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call